Amylyx Pharmaceuticals, Inc. (AMLX)
14.35
+0.13
(+0.91%)
USD |
NASDAQ |
May 29, 16:00
14.35
0.00 (0.00%)
After-Hours: 20:00
Amylyx Pharmaceuticals EPS Diluted (Quarterly) : -0.3734 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Alumis, Inc. | -0.7441 |
| Merck & Co., Inc. | -1.715 |
| Ocular Therapeutix, Inc. | -0.3954 |
| ANI Pharmaceuticals, Inc. | 1.276 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -41.28M |
| Total Expenses (Quarterly) | 41.28M |
| Enterprise Value | 1.321B |
| Earnings Yield | -10.50% |
| Normalized Earnings Yield | -10.50 |